These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3497990)

  • 1. Safety and immunogenicity of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine (PRP-D) in infants.
    Lepow ML; Barkin RM; Berkowitz CD; Brunell PA; James D; Meier K; Ward J; Zahradnik JM; Samuelson J; McVerry PH
    J Infect Dis; 1987 Oct; 156(4):591-6. PubMed ID: 3497990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and immunogenicity of Haemophilus influenzae type b polysaccharide and polysaccharide diphtheria toxoid conjugate vaccines in children 15 to 24 months of age.
    Berkowitz CD; Ward JI; Meier K; Hendley JO; Brunell PA; Barkin RA; Zahradnik JM; Samuelson J; Gordon L
    J Pediatr; 1987 Apr; 110(4):509-14. PubMed ID: 3550021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the combined administration of Haemophilus influenzae type B--diphtheria toxoid conjugate vaccine (PRP-D) and DTP.
    Gordon LK
    Dev Biol Stand; 1986; 65():113-21. PubMed ID: 3549393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and immunogenicity of Haemophilus influenzae type b-polysaccharide diphtheria toxoid conjugate vaccine in infants 9 to 15 months of age.
    Lepow ML; Samuelson JS; Gordon LK
    J Pediatr; 1985 Feb; 106(2):185-9. PubMed ID: 3871477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of antibody and booster responses to reimmunization with Haemophilus influenzae type b polysaccharide and polysaccharide diphtheria toxoid conjugate vaccines in children initially immunized at 15 to 24 months of age.
    Berkowitz CD; Ward JI; Chiu CE; Marcy SM; Gordon L; Hendley JO; Meier K; Marchant CD; McVerry P
    Pediatrics; 1990 Mar; 85(3):288-93. PubMed ID: 2304781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
    Dashefsky B; Wald E; Guerra N; Byers C
    Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infants.
    Granoff DM; Holmes SJ; Belshe RB; Osterholm MT; McHugh JE; Anderson EL
    JAMA; 1994 Oct; 272(14):1116-21. PubMed ID: 7933324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of Haemophilus influenzae type b capsular polysaccharide vaccines in 18-month-old infants.
    Hendley JO; Wenzel JG; Ashe KM; Samuelson JS
    Pediatrics; 1987 Sep; 80(3):351-4. PubMed ID: 3306597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccine in infants.
    Holmes SJ; Fritzell B; Guito KP; Esbenshade JF; Blatter MM; Reisinger KS; Keyserling HL; Rothstein EP; Bernstein HH; Feldman S
    Am J Dis Child; 1993 Aug; 147(8):832-6. PubMed ID: 8352217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trials of the Haemophilus influenzae type b capsular polysaccharide-diphtheria toxoid conjugate vaccine.
    Lepow M
    Pediatr Infect Dis J; 1987 Aug; 6(8):804-7. PubMed ID: 3313246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of PRP-T combined with DTP: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period.
    Miller MA; Meschievitz CK; Ballanco GA; Daum RS
    Pediatrics; 1995 Apr; 95(4):522-7. PubMed ID: 7700752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody levels achieved in infants by course of Haemophilus influenzae type B polysaccharide/diphtheria toxoid conjugate vaccine.
    Eskola J; Käyhty H; Peltola H; Karanko V; Mäkelä PH; Samuelson J; Gordon LK
    Lancet; 1985 May; 1(8439):1184-6. PubMed ID: 2860387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of the Haemophilus influenzae type b capsular polysaccharide conjugate vaccine in children after systemic Haemophilus influenzae type b infections.
    Kaplan SL; Zahradnik JM; Mason EO; Dukes CM
    J Pediatr; 1988 Aug; 113(2):272-7. PubMed ID: 3260943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited efficacy of a Haemophilus influenzae type b conjugate vaccine in Alaska Native infants. The Alaska H. influenzae Vaccine Study Group.
    Ward J; Brenneman G; Letson GW; Heyward WL
    N Engl J Med; 1990 Nov; 323(20):1393-401. PubMed ID: 2233906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study Group.
    Schlesinger Y; Granoff DM
    JAMA; 1992 Mar; 267(11):1489-94. PubMed ID: 1538539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines.
    Decker MD; Edwards KM; Bradley R; Palmer P
    J Pediatr; 1992 Feb; 120(2 Pt 1):184-9. PubMed ID: 1735812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of infants to Haemophilus influenzae type b polysaccharide and diphtheria-tetanus-pertussis vaccines in combination.
    Lepow ML; Peter G; Glode MP; Daum RS; Calnen G; Knight KM; Mayer D; Kuo JS; Lui NS
    J Infect Dis; 1984 Jun; 149(6):950-5. PubMed ID: 6376656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate): immunogenicity and safety at various doses.
    Yogev R; Arditi M; Chadwick EG; Amer MD; Sroka PA
    Pediatrics; 1990 Apr; 85(4 Pt 2):690-3. PubMed ID: 2107520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of Haemophilus influenzae type b conjugate vaccines in infant rhesus monkeys.
    Vella PP; Ellis RW
    Pediatr Res; 1991 Jan; 29(1):10-3. PubMed ID: 2000253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody responses to Haemophilus influenzae type B vaccines in men with human immunodeficiency virus infection.
    Steinhoff MC; Auerbach BS; Nelson KE; Vlahov D; Becker RL; Graham NM; Schwartz DH; Lucas AH; Chaisson RE
    N Engl J Med; 1991 Dec; 325(26):1837-42. PubMed ID: 1683682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.